Inhibitory effects of iron on bone morphogenetic protein 2–induced osteoblastogenesis
Open Access
- 2 February 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 26 (6), 1188-1196
- https://doi.org/10.1002/jbmr.337
Abstract
Postmenopausal osteoporosis is characterized by an imbalance of bone resorption exceeding bone formation, resulting in a net loss of bone mineral density (BMD). Estrogen deficiency is known to promote bone resorption. However, the causative factors that impair bone formation have not been identified. Women after menopause experience not only estrogen deficiency but also iron accumulation as a result of cessation of menstruation. In this study we investigated whether increased iron plays a role in osteoporosis. By growing primary mouse osteoclast and osteoblast progenitor cells as well as immortalized cell lines in the presence of iron, we found that increased iron had minimal effects on osteoclast cell differentiation. Interestingly, iron, particularly in its inorganic form, and to a lesser extent ferritin and transferrin all suppressed alkaline phosphatase (ALP) activities in osteoblasts. Moreover, iron downregulated mRNA levels of several other osteoblastogenic markers such as Runx2, osterix, osteopontin, and osteocalcin. To further show that this in vitro finding is relevant to the in vivo condition, we demonstrated that iron‐accumulated mice with intact ovaries exhibited a significant decrease in BMD. Although iron inhibited preosteoblast cell differentiation, it did enhance preosteoblast cell proliferation, as evidenced by increased cell growth and expression of cell cycle regulator genes such as CDK4, CDK6, cyclin D1, and cyclin D3 and G2/M phase cell population. Taken together, our results suggest that increased iron could be a factor that slows down bone formation in postmenopausal women. © 2011 American Society for Bone and Mineral Research.Keywords
This publication has 41 references indexed in Scilit:
- Bone loss caused by iron overload in a murine model: importance of oxidative stressBlood, 2010
- Excess iron inhibits osteoblast metabolismToxicology Letters, 2009
- Iron and Menopause: Does Increased Iron Affect the Health of Postmenopausal Women?Antioxidants and Redox Signaling, 2009
- Inhibition of osteoblastic bone formation by nuclear factor-κBNature Medicine, 2009
- Reliability of Serum Assays of Iron Status in Postmenopausal WomenAnnals of Epidemiology, 2007
- Alkaline PhosphatasesPurinergic Signalling, 2006
- Mechanisms of sex steroid effects on boneBiochemical and Biophysical Research Communications, 2005
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- Core-binding factor α1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5Bone, 2002
- Medical Expenditures for the Treatment of Osteoporotic Fractures in the United States in 1995: Report from the National Osteoporosis FoundationJournal of Bone and Mineral Research, 1997